RISE Study: Lucentis is superior to laser for diabetic macular edema

The treatment options for diabetic macular edema continues to grow. Anti-VEGF therapies appear to be very effective, but suffer from short-term benefit and the need for continual retreatment. Sustained release steroid implants (Iluvien) is another recent development for DME. The advantage Iluvien has over Lucentis is that it is administered as a 2...

Full Article

Omega-3 fatty acid and fish intake prevents AMD

DHA and EPA are the "active ingredients" of fish oil. This study finds that greater dietary intake of fish oil, or eating fish at least once per week, can help prevent the onset of AMD. This finding is significant because most research focuses on ways to slow the progression of AMD among those that already have the disease. We have much less...

Full Article

Lucentis for wet AMD with very low vision

There is some controversy regarding the benefit of anti-VEGF therapy for patients with very poor vision and/or long-standing maculopathy. It is thought that many of these patients may have scarring of the macula that could prevent them from responding favorably to treatment. A few small studies have been performed on this patient population with...

Full Article

Association between asymmetry in cataract and asymmetry in AMD

There is continuing controversy regarding what, if any, risk cataract surgery conveys toward the development of AMD. The concern regarding cataract surgery stems largely from the fact that more blue light will reach the retina after a cataract is removed, and blue light has a higher potential to cause oxidative damage. Most studies that have...

Full Article